ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

SNSS Sunesis Pharmaceuticals Inc

5.32
0.00 (0.00%)
14 Jun 2024 - Closed
Delayed by 15 minutes

Sunesis Pharmaceuticals Financial Summary

The current SNSS market cap is 205.49M. The company's latest EPS is USD -1.3219 and P/E is -0.50.

Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000
Operating Income -12.21M-12.45M-12.48M-13.56M-13.88M
Net Income -12.21M-12.48M-12.6M-13.77M-9.14M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 2.07M120k13.5M00
Operating Income -23.29M-22.3M-114.28M-50.59M-50.69M
Net Income -23.33M-21.61M-114.76M-49.2M-51.06M
Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 85.78M76.86M66.44M56.69M41.33M
Total Liabilities 34.67M36.08M36.43M38.37M30.25M
Total Equity 51.11M40.78M30.01M18.32M11.08M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 37.24M23.25M108.55M95.99M56.69M
Total Liabilities 9.7M3.31M14.18M34.89M38.37M
Total Equity 27.54M19.94M94.37M61.1M18.32M
Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -11.34M-19.33M-29.87M-39.89M-7.85M
Investing -7.35M-3.37M5.73M15M14.19M
Financing 16k220k220k438k-6.6M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -22.19M-21.44M-18.85M-35.46M-39.89M
Investing -16.29M16.41M12.89M-53.87M15M
Financing 43.04M7.18M62.43M22.54M438k
Market Cap 205.49M
Price to Earnings Ratio -0.50
Price to Sales Ratio 0
Price to Cash Ratio 2.07
Price to Book Ratio 1.39
Dividend Yield -

Share Statistics

Shares Outstanding 38.63M
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change -
52 Week High -
52 Week Low -
Spread (Intraday) 0.03 (0.63%)

Company Info

Company Name Sunesis Pharmaceuticals Inc
Address 1209 orange street
wilmington, delaware 19801
Website https://www.viracta.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock